WB
XERS icon

Webster Bank’s Xeris Biopharma Holdings XERS Stock Holding History

Webster Bank’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15K Hold
1,900
– – ﹤0.01% 483
2026
Q1 		$11K Sell
1,900
-1,100
-37% -$7.29K ﹤0.01% 513
2025
Q4 		$23.6K Sell
3,000
-1,000
-25% -$7.87K ﹤0.01% 432
2025
Q3 		$32.6K Buy
4,000
+1,000
+33% +$6.64K ﹤0.01% 403
2025
Q2 		$14K Hold
3,000
– – ﹤0.01% 467
2025
Q1 		$16.5K Buy
+3,000
New +$12.1K ﹤0.01% 446

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Webster Bank's XERS Position: Q2 2026 in Review

Webster Bank held its Xeris Biopharma Holdings (XERS) position steady in Q2 2026 at 1,900 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #483.

Webster Bank first reported a position in XERS in Q1 2025 and has held it in 6 quarters since. The position peaked at $32.6K in Q3 2025. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Webster Bank held 1,900 shares of Xeris Biopharma Holdings worth $15K as of Q2 2026.
  • Webster Bank left its Xeris Biopharma Holdings share count unchanged in Q2 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of Webster Bank's portfolio in Q2 2026, its #483 holding.
  • Webster Bank first reported a position in Xeris Biopharma Holdings in Q1 2025 and has held it in 6 quarters since.
  • Webster Bank's Xeris Biopharma Holdings position peaked at $32.6K in Q3 2025.
  • 241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Webster Bank's 13F filing for Q2 2026, filed 20 Jul 2026.